HHC vape pen

The HHC electronic cigarette pen is an electronic smoking device containing hexahydrocannabinol. It has been classified as a controlled substance in China, and its use and possession are both illegal.

HHC is a semi-synthetic cannabinoid, often promoted as a "legal" alternative to THC (tetrahydrocannabinol, the main psychoactive component of cannabis). It typically appears in the form of a disposable electronic cigarette pen and generates inhalable aerosol through heating.

⚠️ Main risks and side effects
The safety and long-term effects of HHC are very limited, but existing reports have revealed significant health risks:

Mental health risks: This is the most concerning aspect. Reports have indicated that HHC can trigger severe psychotic episodes, including delusions, auditory hallucinations, paranoia, and detachment from reality. A study showed that during a 21-month period in a hospital, HHC was the second most common drug causing patients to develop psychosis.

Common adverse reactions: A survey of HHC users revealed that up to 89.9% of respondents experienced at least one negative consequence in the past year. Common side effects include:

Anxiety or panic reactions (14.7%)

Dizziness or fainting (13.4%)

Disintegration of personality or loss of reality sense (11.9%)

Memory and attention problems

Nausea, vomiting, and breathing problems

Addiction and withdrawal: Users report that HHC is highly addictive, and frequent use can lead to withdrawal symptoms.

⚖️ Legal status
The legality of HHC is rapidly changing worldwide, and it is strictly prohibited in China.

In China: According to a joint announcement by the Ministry of Public Security, the National Health Commission, and the National Medical Products Administration on June 6, 2025, hexahydrocannabinol (HHC) has been included in the "Supplementary Catalogue of Controlled Substances for Non-Pharmaceutical Anesthetic Drugs and Psychotropic Substances". This announcement came into effect on July 1, 2025. This means that any production, sale, possession, import, and use of HHC within China is illegal.

In other countries: In Ireland, HHC was classified as a Schedule 1 controlled drug on July 2025 and is completely prohibited. HHC has also been included in Appendix II of the 1971 "Convention on Psychotropic Substances" by the United Nations Drug Control Commission. In the United States, its legal status varies by state, but federal regulation is strengthening.

User experience and market situation
Despite the extremely high risks, some user reviews can still be found online. Some users describe their experience as "very relaxing" or "effective", but others report that the effect is "very slight". These differences in user experiences are significant, and the product lacks regulation, making it impossible to guarantee its composition and purity.